Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer.

International journal of molecular sciences

Volumn 14, Issue 8, 2013, Pages 16617-16637

  Yin, Yan ^a   Kizer, Nora T ^b   Thaker, Premal H ^b   Chiappinelli, Katherine B ^b   Trinkaus, Kathryn M ^b   Goodfellow, Paul J ^b   Ma, Liang ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; IMMUNOLOGICAL ADJUVANT; LITHIUM CHLORIDE; N-(4-METHOXYBENZYL)-N'-(5-NITRO-1,3-THIAZOL-2-YL)UREA; PACLITAXEL; THIAZOLE DERIVATIVE; UREA;

ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL PROLIFERATION; DRUG EFFECTS; DRUG POTENTIATION; DRUG SCREENING; ENDOMETRIAL NEOPLASMS; FEMALE; HUMAN; M PHASE CELL CYCLE CHECKPOINT; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SYNERGISM; ENDOMETRIAL NEOPLASMS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LITHIUM CHLORIDE; M PHASE CELL CYCLE CHECKPOINTS; MICE; NEOPLASM TRANSPLANTATION; PACLITAXEL; SIGNAL TRANSDUCTION; THIAZOLES; UREA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84892434488     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140816617     Document Type: Article

References (0)